Curanex Pharmaceuticals CURX
NASDAQ CURX
$5.01 +0.39 (+8.43%)
As of: Oct 21, 2026 · 2:44 PM EDT

Curanex Pharmaceuticals (CURX) Common Equity (2024 - 2026)

Updated

Curanex Pharmaceuticals' Common Equity came in at $4.79 million for Q2 2026, compared with $305,431 a year earlier.

Analysis

Curanex Pharmaceuticals (CURX) Common Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Curanex Pharmaceuticals' Common Equity was $11.22 million.

  • Going back by year, Common Equity was $503,360 in FY2024.
  • The five-year range for quarterly Common Equity is $305,431 (Q2 2025) to $14.29 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 84.97 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -5.94 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 50.37 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 85.49 Bn
10 Curanex Pharmaceuticals 7.11 Mn -6.75 Mn - 4.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.79 Mn
Dec 31, 2025 11.22 Mn
Sep 30, 2025 14.29 Mn
Jun 30, 2025 305,431.00
Dec 31, 2024 503,360.00
Sep 30, 2024 624,165.00
Jun 30, 2024 715,231.00
API Access

Curanex Pharmaceuticals Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=CURX&period=max&api_key=YOUR_API_KEY